Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo.

Serum sex hormone-binding globulin (SHBG) and insulin-like growth factor-binding protein 1 (IGFBP-1) concentrations have been suggested to be useful markers of insulin sensitivity. As the production of both proteins is inhibited by insulin in the liver, we postulated that their concentrations reflect whole body insulin sensitivity only when the latter parallels changes in endogenous insulin secretion. To test this hypothesis, we determined SHBG and IGFBP-1 concentrations, whole body insulin sensitivity (euglycemic insulin clamp; serum free insulin, approximately 400 pmol/L), and serum insulin and C peptide concentrations in 13 type 1 diabetic patients lacking endogenous insulin secretion and 34 matched normal subjects. Whole body insulin sensitivity was 50% lower in the type 1 diabetic patients (20 +/- 3 mumol/kg.min) than that in the normal subjects (40 +/- 3 mumol/kg.min; P < 0.001). Despite this, serum SHBG (45 +/- 4 vs. 29 +/- 2nmol/L; P < 0.002) and IGFBP-1 (14 +/- 3 vs. 2 +/- 1 micrograms/L; P < 0.002) concentrations were increased in the type 1 diabetic patients. In the normal subjects, SHBG (r = -0.49; P < 0.01) and IGFBP-1 (r = -0.49; P < 0.01) were inversely correlated with serum C peptide and positively correlated with whole body insulin sensitivity (r = 0.54; P < 0.005 and r = 0.54; P < 0.005, respectively). In the type 1 diabetic patients, SHBG and IGFBP-1 concentrations were disproportionately increased when related to insulin sensitivity, but appropriate when related to estimated portal insulin concentrations. Serum T4, free testosterone, and estradiol concentrations were similar in both groups. We conclude that SHBG and IGFBP-1 reflect hepatic insulinization and can only be used as markers of insulin sensitivity in individuals with intact insulin secretion.

[1]  K. Wiechel,et al.  Insulin in portal, hepatic and peripheral venous blood after glucose, tolbutamide and glipizide stimulation. Indication of insulin release from peripheral tissues. , 2009, Acta medica Scandinavica.

[2]  K. Wiechel,et al.  Comparsion of the effect of intraportal and intravenous infusion of insulin on blood glucose and free fatty acids in peripheral venous blood of man. , 2009, Acta medica Scandinavica.

[3]  J. Wahren,et al.  Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. , 1994, The Journal of clinical endocrinology and metabolism.

[4]  P. Thulé,et al.  Insulin and glucocorticoids regulate IGFBP-1 expression via a common promoter region. , 1994, Biochemical and biophysical research communications.

[5]  J. Thissen,et al.  Differential regulation of insulin-like growth factor I (IGF-I) and IGF binding protein-1 messenger ribonucleic acids by amino acid availability and growth hormone in rat hepatocyte primary culture. , 1994, Endocrinology.

[6]  M. Laakso,et al.  Insulin Resistance, Body Fat Distribution, and Sex Hormones in Men , 1994, Diabetes.

[7]  T. Unterman,et al.  Functional analysis of glucocorticoid and insulin response sequences in the rat insulin-like growth factor-binding protein-1 promoter. , 1994, Endocrinology.

[8]  R. Koistinen,et al.  Response of sex hormone binding globulin and insulin‐like growth factor binding protein‐1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction , 1993, Clinical endocrinology.

[9]  D. Powell,et al.  Identification of an insulin-responsive element in the promoter of the human gene for insulin-like growth factor binding protein-1. , 1993, The Journal of biological chemistry.

[10]  U. Stenman,et al.  Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls. , 1993, The Journal of clinical endocrinology and metabolism.

[11]  S. Haffner,et al.  Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men. , 1993, The Journal of clinical endocrinology and metabolism.

[12]  M. Välimäki,et al.  Thyroxine withdrawal is accompanied by decreased circulating levels of insulin-like growth factor-binding protein-1 in thyroidectomized patients. , 1993, The Journal of clinical endocrinology and metabolism.

[13]  R. Koistinen,et al.  Tri-iodothyronine and cycloheximide enhance insulin-like growth factor-binding protein-1 gene expression in human hepatoma cells. , 1993, Journal of molecular endocrinology.

[14]  E. Barrett-Connor,et al.  Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the telecom study. , 1993, The Journal of clinical endocrinology and metabolism.

[15]  J. Nestler.  Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? , 1993, The Journal of clinical endocrinology and metabolism.

[16]  R. N. Bergman,et al.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study , 1992, The Lancet.

[17]  S. Haffner,et al.  Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women. , 1992, Metabolism: clinical and experimental.

[18]  J. Crave,et al.  Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[19]  S. Franks,et al.  The role of nutrition and insulin in the regulation of sex hormone binding globulin , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[20]  K. Noonan,et al.  DECREASED SEX HORMONE BINDING GLOBULIN (SHBG) AND INSULIN‐LIKE GROWTH FACTOR BINDING PROTEIN (IGFBP‐1) IN EXTREME OBESITY , 1990, Clinical endocrinology.

[21]  S. Haffner,et al.  Incidence of Type II Diabetes in Mexican Americans Predicted by Fasting Insulin and Glucose Levels, Obesity, and Body-Fat Distribution , 1990, Diabetes.

[22]  R. Koistinen,et al.  Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells. , 1990, The Journal of endocrinology.

[23]  K. Sahlin,et al.  Localization of Rate-Limiting Defect for Glucose Disposal in Skeletal Muscle of Insulin-Resistant Type I Diabetic Patients , 1990, Diabetes.

[24]  A. Consoli,et al.  Mechanism for Underestimation of Isotopically Determined Glucose Disposal , 1989, Diabetes.

[25]  T. Laatikainen,et al.  Decreased 34K insulin-like growth factor binding protein in polycystic ovarian disease. , 1989, Fertility and sterility.

[26]  T. Chard,et al.  ORCADIAN VARIATION OF GH‐INDEPENDENT IGF‐BINDING PROTEIN IN DIABETES MELLITUS AND ITS RELATIONSHIP TO INSULIN. A NEW ROLE FOR INSULIN? , 1988, Clinical endocrinology.

[27]  K. Brismar,et al.  Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus , 1988, Journal of endocrinological investigation.

[28]  Robert E. Jones,et al.  Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. , 1988, The Journal of clinical endocrinology and metabolism.

[29]  B V Howard,et al.  Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. , 1988, The New England journal of medicine.

[30]  M. Seppälä,et al.  Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. , 1988, The Journal of clinical endocrinology and metabolism.

[31]  P. Cryer,et al.  Failure of nocturnal hypoglycemia to cause fasting hyperglycemia in patients with insulin-dependent diabetes mellitus. , 1987, The New England journal of medicine.

[32]  H. Yki-Järvinen,et al.  Kinetics of glucose disposal in whole body and across the forearm in man. , 1987, The Journal of clinical investigation.

[33]  P. Brunetti,et al.  Comparison of Glucose Counterregulation During Short-Term and Prolonged Hypoglycemia in Normal Humans , 1986, Diabetes.

[34]  C. Hagen,et al.  SERUM SEX HORMONE CONCENTRATIONS IN INSULIN DEPENDENT DIABETIC WOMEN WITH AND WITHOUT AMENORRHOEA , 1985, Clinical endocrinology.

[35]  P. Cryer,et al.  Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. , 1985, The New England journal of medicine.

[36]  P. Cryer,et al.  Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. , 1984, The New England journal of medicine.

[37]  R. DeFronzo,et al.  Regulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man , 1983, Diabetes.

[38]  R. DeFronzo,et al.  The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization , 1981, Diabetes.

[39]  R. M. Walter,et al.  Portal and peripheral vein concentrations of insulin and glucagon after arginine infusion in morbidly obese subjects. , 1980, Metabolism: clinical and experimental.

[40]  W. Bartsch.  Interrelationships between sex hormone-binding globulin and testosterone, 5α-dihydrotestosterone and oestradiol- 7β in blood of normal men , 1980 .

[41]  J. Holst,et al.  Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal. , 1980, Diabete & metabolisme.

[42]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[43]  G. Bray,et al.  Low serum testosterone and sex-hormone-binding-globulin in massively obese men. , 1977, The Journal of clinical endocrinology and metabolism.

[44]  D L Horwitz,et al.  Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.

[45]  W. Blackard,et al.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. , 1975, The Journal of clinical investigation.

[46]  B. Desbuquois,et al.  Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. , 1971, The Journal of clinical endocrinology and metabolism.

[47]  W. Blackard,et al.  Portal and Peripheral Vein Immunoreactive Insulin Concentrations Before and After Glucose Infusion , 1970, Diabetes.

[48]  J. Sternberg,et al.  A New and Rapid Method for the Determination of Glucose by Measurement of Rate of Oxygen Consumption , 1968 .

[49]  J. Clore,et al.  A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. , 1991, The Journal of clinical endocrinology and metabolism.

[50]  R. Pasquali,et al.  Effect of obesity and body fat distribution on sex hormones and insulin in men. , 1991, Metabolism: clinical and experimental.

[51]  R. Koistinen,et al.  Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. , 1989, The Journal of clinical endocrinology and metabolism.